Edward Murphy, MD, MPH

Laperche S, Boukatou G, Kouegnigan L, Nébié Y, Boulahi MO, Tagny CT, Yahaya R, Tapko JB, Murphy E, Lefrère JJ. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion. 2009 Aug; 49(8):1600-8.

Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, Barbeau B, Mahieux R. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood. 2009 Sep 17; 114(12):2427-38.

Murphy EL, Shaz B, Hillyer CD, Carey P, Custer BS, Hirschler N, Fang J, Schreiber GB. Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. Transfusion. 2009 Oct; 49(10):2221-8.

Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009 Sep; 49(9):1825-35.

DeVita DA, White MC, Zhao X, Kaidarova Z, Murphy EL. Determinants of subject visit participation in a prospective cohort study of HTLV infection. BMC Med Res Methodol. 2009 Mar 10; 9:19.

Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 2009 Feb; 49(2):278-88.

de Almeida Neto C, Murphy EL, McFarland W, Junior AM, Chen S, Chamone DA, Sabino EC. Profile of blood donors with serologic tests reactive for the presence of syphilis in São Paulo, Brazil. Transfusion. 2009 Feb; 49(2):330-6.

Bartman MT, Kaidarova Z, Hirschkorn D, Sacher RA, Fridey J, Garratty G, Gibble J, Smith JW, Newman B, Yeo AE, Murphy EL. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood. 2008 Nov 15; 112(10):3995-4002.

Goncalez TT, Sabino EC, Chen S, Salles NA, Chamone DA, McFarland W, Murphy EL. Knowledge, attitudes and motivations among blood donors in São Paulo, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S39-47.

Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, Cyrus S, Busch MP, Murphy EL. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol. 2008 Mar 15; 167(6):743-50.

Nguyen DD, Devita DA, Hirschler NV, Murphy EL. Blood donor satisfaction and intention of future donation. Transfusion. 2008 Apr; 48(4):742-8.

Schlumpf KS, Glynn SA, Schreiber GB, Wright DJ, Randolph Steele W, Tu Y, Hermansen S, Higgins MJ, Garratty G, Murphy EL. Factors influencing donor return. Transfusion. 2008 Feb; 48(2):264-72.

Madden E, Murphy EL, Custer B. Modeling red cell procurement with both double-red-cell and whole-blood collection and the impact of European travel deferral on units available for transfusion. Transfusion. 2007 Nov; 47(11):2025-37.

Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL. The consequences of temporary deferral on future whole blood donation. Transfusion. 2007 Aug; 47(8):1514-23.

de Almeida Neto C, McFarland W, Murphy EL, Chen S, Nogueira FA, Mendrone A, Salles NA, Chamone DA, Sabino EC. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Transfusion. 2007 Apr; 47(4):608-14.

Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis. 2007 May 01; 44(9):1229-34.

Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006 Dec 01; 194(11):1557-64.

De Castro-Costa CM, Araújo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses. 2006 Oct; 22(10):931-5.

Reich P, Roberts P, Laabs N, Chinn A, McEvoy P, Hirschler N, Murphy EL. A randomized trial of blood donor recruitment strategies. Transfusion. 2006 Jul; 46(7):1090-6.

Glynn SA, Schreiber GB, Murphy EL, Kessler D, Higgins M, Wright DJ, Mathew S, Tu Y, King M, Smith JW. Factors influencing the decision to donate: racial and ethnic comparisons. Transfusion. 2006 Jun; 46(6):980-90.

Barcellos NT, Fuchs SC, Mondini LG, Murphy EL. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil. Sex Transm Dis. 2006 May; 33(5):302-6.

Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion. 2006 Mar; 46(3):469-75.

Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, Murphy EL, Sabino EC, Hisada M, Galvão-Castro B, Alcantara LC, Remondegui C, Verdonck K, Proietti FA. HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica. 2006 Jan; 19(1):44-53.

Gabet AS, Moulés V, Sibon D, Nass CC, Mortreux F, Mauclère P, Gessain A, Murphy EL, Wattel E. Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology. 2006 Feb 05; 345(1):13-21.

Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005 Sep 05; 24(39):6058-68.